I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defribillator

Journal of Nuclear Cardiology

Volumn 10, Issue 2, 2003, Pages 121-131

  Arora, Rishi ^a   Ferrick, Kevin J ^a   Nakata, Tomoaki ^b   Kaplan, Robert C ^a   Rozengarten, Michael ^a   Latif, Farhana ^a   Ng, Kaman ^a   Marcano, Vanessa ^a   Heller, Sherman ^a   Fisher, John D ^a   Travin, Mark I ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Heart rate variability; Implantable cardioverter defibrillator; Iodine 123 metaiodobenzylyguanidine imaging; Sudden cardiac death

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GUANIDINE DERIVATIVE; IODINE 123; IODINE 123 METAIODOBENZYLGUANIDINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; UNCLASSIFIED DRUG;

ADULT; AGED; ARRHYTHMOGENESIS; ARTICLE; AUTONOMIC INNERVATION; AUTONOMIC NERVOUS SYSTEM FUNCTION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEFIBRILLATOR; DRUG TRANSPORT; ECHOCARDIOGRAPHY; FATALITY; FEMALE; FREQUENCY ANALYSIS; HEART DENERVATION; HEART RATE VARIABILITY; HEART SCINTISCANNING; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; IMAGE ANALYSIS; MALE; NEUROPHYSIOLOGY; PATIENT SELECTION; PILOT STUDY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC INNERVATION;

EID: 0037366184     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2003.2     Document Type: Article

References (50)

1. Myerburg RJ, Castellanos A. Cardiac arrest and sudden death. In: Braunwald E, editor. Heart disease: a textbook of cardiovascular medicine. Philadelphia: Saunders; 1997. p. 742-79.
2. Zipes DP, Wellens HJJ. Sudden cardiac death. Circulation 1998; 98:2334-51.
3. O'Brien BJ, Connolly SJ, Goeree R, et al, for the CIDS investigators. Cost-effectiveness of the implantable cardioverter-defibrillator. Results from the Canadian Defibrillator Study (CIDS). Circulation 2001;103:1416-21.
4. Moss AJ, Hall WJ, Cannon DS, et al, for the Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmias. N Engl J Med 1996;335:1933-40.
5. Buxton AE, Lee KL, Fisher JD, et al, for the Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999;341:1882-90.
6. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-83.
7. Kuck K, Cappato R, Siebels J, Rüppel R, for the CASH Investigators. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. The Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-54.
8. Moss AJ, Zareba W, Hall WJ, et al, for the Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
9. Exner DV, Klein GJ, Prystowsky EN. Primary prevention of sudden death with implantable defibrillator therapy in patients with cardiac disease. Circulation 2001;104:1564-70.
10. Bigger JT. Expanding indications for implantable cardiac defibrillators. N Engl J Med 2002;346:931-2.
11. Hallstrom AP, McAnulty JH, Wilkoff BL, et al, and the Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators. Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefit. Circulation 2001;37:1093-9.
12. Zipes DP. A century of cardiac arrhythmias. J Am Coll Cardiol 1999;34:959-65.
13. Zipes DP, Wellens HJJ. What have we learned about cardiac arrhythmias? Circulation 2000;102:IV52-7.
14. Barron HV, Lesh MD. Autonomic nervous system and sudden cardiac death. J Am Coll Cardiol 1996;27:1053-60.
15. Barron HV, Viskin S. Autonomic markers and prediction of cardiac death after myocardial infarction. Lancet 1998;351: 461-2.
16. The Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Circulation 1996;93:1043-65.
17. Hattori N, Schwaiger M. Metaiodobenzylguanidine scintigraphy of the heart: what have we learnt clinically? Eur J Nucl Med 2000;27:1-6.
18. Merlet P, Valette H, Dubois-Randé JL, et al. Prognostic value of cardiac MIBG imaging in patients with heart failure. J Nucl Med 1992;33:471-7.
19. Nakata T, Miyamoto K, Doi A, et al. Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts. J Nucl Cardiol 1998;5: 579-90.
20. Kleiger RE, Miller JP, Bigger JT, Moss AJ, and the Multicenter Post-Infarction Research Group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256-62.
21. Farrell TG, Bashir Y, Cripps T, et al. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol 1991;18:687-97.
22. Bigger JT, Fleiss JL, Rolnitzky LM, Steinman RC. The ability of several short-term measures of RR variability to predict mortality after myocardial infarction. Circulation 1993;88:927-34.
23. Mitrani RD, Klein LS, Miles WM, et al. Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease. J Am Coll Cardiol 1993;22:1344-53.
24. Stanton MS, Tuli MM, Radtke NL, et al. Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-MIBG. J Am Coll Cardiol 1989;14: 1519-26.
25. Bigger JT Jr, Fleiss JL, Steinman RC, et al. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992;85:164-71.
26. Morozumi T, Kusuoka H, Fukuchi K, et al. Myocardial iodine-123-metaiodobenzylguanidine images and autonomic nerve activity in normal subjects. J Nucl Med 1997;38:49-52.
27. Lotze U, Kober A, Kaepplinger S, et al. Cardiac sympathetic activity as measured by myocardial 123-I-metaiodobenzylguanidine uptake and heart rate variability in idiopathic dilated cardiomyopathy. Am J Cardiol 1999;83:1548-51.
28. Hohnsloser SH, Klingenheben T, Li YG, et al. T-wave afternans as a predictor of recurrent ventricular tachyarrhythmias in ICD patients: prospective comparison with conventional risk markers. J Cardiovasc Electrophysiol 1998;9:1258-68.
29. Port SC, editor. Imaging guidelines for nuclear cardiology procedures. Part 2. J Nucl Cardiol 1999;6:G70-1.
30. Huikuri HV, Castellanos A, Myerberg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001;345:1473-82.
31. Echt DS, Liebson PR, Mitchell LB, et al, and the CAST Investigators. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991;324:781-8.
32. Waldo AL, Camm AJ, deRuyter H, et al, for the SWORD Investigators. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996;348:7-12.
33. Singh SH, Fletcher RD, Fisher SG, et al, for the Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. Amiodarone in patients with congestive heart failure and symptomatic ventricular arrhythmias. N Engl J Med 1995;333:77-82.
34. Myerburg RJ, Mitrani R, Interian A Jr, Castellanos A. Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. Circulation 1998;97:1514-21.
35. Engelstein E, Sawada SG, Hutchins GD, et al. Sympathetic denervation in patients following acute myocardial infarction. Relationship to myocardial perfusion and metabolism [abstract]. J Am Coll Cardiol 1998;31:526A.
36. La Rovere MT, Bigger JT Jr, Marcus FI, et al, on behalf of the ATRAMI Investigators. Prognostic value of depressed baroreflex sensitivity: the ATRAMI study [abstract]. Circulation 1995; 92(Suppl I):I-676.
37. Zipes DP. Sympathetic stimulation and arrhythmias. N Engl J Med 1991;325:656-7.
38. Merlet P, Benvenuti C, Moyse D, et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 1999; 40:917-23.
39. Schofer J, Spielmann R, Schuchert A, Weber K, Schlüter M. Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1988;12:1252-8.
40. Gioia G, Bagheri B, Gottlieb CD, et al. Prediction of outcome of patients with life-threatening ventricular arrhythmias treated with automatic implantable cardioverter-defibrillators using SPECT perfusion imaging. Circulation 1997;95:390-4.
41. Gradel C, Jain D, Batsford WP, Wackers FJT, Zaret BL. Relationship of scar and ischemia to the results of programmed electrophysiological stimulation in patients with coronary artery disease. J Nucl Cardiol 1997;4:379-86.
42. Bigger JT. Clinical assessment of the autonomic nervous system. In: Topol EJ, editor. Comprehensive cardiovascular medicine. Philadelphia: Lippincott-Raven; 1998. p. 2185-205.
43. Casadei B, Cochrane S, Johnston J, et al. Pitfalls in interpretation of spectral analysis of the heart rate variability during exercise in humans. Acta Physiol Scand 1995;153:125-31.
44. Lombardi F, Malliani A, Pagani M, Cerutti S. Heart rate variability and its sympatho-vagal modulation. Cardiovasc Res 1996;32:208-16.
45. Lombardi F. Frequency domain analysis of HRV. In: Zareba W, Maison-Blanche P, Locati E, editors. Noninvasive electrocardiology in clinical practice. New York: Futura; 2001. p. 163-80.
46. Moss AJ, Stern S. Noninvasive electrocardiography: clinical aspects of holter monitoring. London: Saunders; 1996.
47. Ponikowski P, Anker SD, Chua TP, et al. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1997;79:1645-50.
48. 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after β-blocker or angiotensin converting enzyme inhibitor therapy. J Nucl Med 1999;40:217-23.
49. Takeishi Y, Atsumi H, Fujiwara S, Takahashi K, Tomoike H. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure. J Nucl Med 1997;38:1085-9.
50. 123I-metaiodobenzylguanidine uptake. J Nucl Med